ARTICLE | Company News
Finch, Takeda deal
April 7, 2017 8:02 PM UTC
Finch granted Takeda exclusive, worldwide rights to develop and commercialize FIN-524 and follow-on products to treat inflammatory bowel disease (IBD). Finch will receive $10 million up front and is e...
BCIQ Company Profiles